Early use of N-acetylcysteine with nitrate therapy in patients undergoing primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction reduces myocardial infarct size (the NACIAM trial [N-acetylcysteine in acute myocardial infarction])

Sivabaskari Pasupathy, Rosanna Tavella, Suchi Grover, Betty Raman, Nathan Procter, Yang Du, Gnanadevan Mahadavan, Irene Stafford, Tamila Heresztyn, Andrew Holmes, Christopher Zeitz, Margaret Arstall, Joseph Selvanayagam, John Horowitz, John Beltrame

Research output: Contribution to journalArticlepeer-review

111 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Early use of N-acetylcysteine with nitrate therapy in patients undergoing primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction reduces myocardial infarct size (the NACIAM trial [N-acetylcysteine in acute myocardial infarction])'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science